Advanced Research in Scleral Cross-Linking to Prevent From Progressive Myopia.
Sign Up to like & getrecommendations! Published in 2021 at "Asia-Pacific Journal of Ophthalmology"
DOI: 10.1097/apo.0000000000000340
Abstract: ABSTRACT Riboflavin-ultraviolet A (UVA) collagen cross-linking (CXL) has been applied in clinical settings to prevent the progression of keratoconus and corneal dilatation caused by other reasons in past decades. As CXL with riboflavin-UVA can enhance… read more here.
Keywords: myopia; cross linking; riboflavin uva; advanced research ... See more keywords